Lupin informs about press release

25 Jan 2021 Evaluate

Lupin has informed that it has enclosed a Press Release as regards receipt of USFDA approval for the Company's Sevelamer Carbonate Tablets, 800 mg, to market a generic equivalent of Renvela Tablets, 800 mg, of Genzyme Corporation.

The above information is a part of company’s filings submitted to BSE.

Lupin Share Price

2355.10 23.35 (1.00%)
25-Mar-2026 14:10 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1805.70
Dr. Reddys Lab 1307.25
Cipla 1252.30
Zydus Lifesciences 911.80
Lupin 2355.10
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×